(Q35978157)

English

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Positive effect of tamoxifen as part of adjuvant chemo-endocrine therapy for breast cancer. Hokkaido Adjuvant Chemo-Endocrine Therapy for Breast Cancer Study Group (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

author name string

Uchino J

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Samejima N

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Tanabe T

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Hayasaka H

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mito M

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Hata Y

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Asaishi K

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 April 1994

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

69

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

767-771

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968816

2 October 2017

[Chemo-endocrine therapy for advanced breast cancer--a combined treatment with tamoxifen and FT 207-- (author's transl)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8142265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/8142265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/8142265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centre

1 reference

https://pubmed.ncbi.nlm.nih.gov/8142265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8142265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1994.145

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35978157&oldid=2198018019"